+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Dysmenorrhea Treatment Market by Type (Primary Dysmenorrhea, Secondary Dysmenorrhea), Treatment (Medication, Surgery, Therapeutics), Distribution Channel, End-Users - Forecast 2024-2030- Product Image
Global Dysmenorrhea Treatment Market by Type (Primary Dysmenorrhea, Secondary Dysmenorrhea), Treatment (Medication, Surgery, Therapeutics), Distribution Channel, End-Users - Forecast 2024-2030- Product Image
Sale

Global Dysmenorrhea Treatment Market by Type (Primary Dysmenorrhea, Secondary Dysmenorrhea), Treatment (Medication, Surgery, Therapeutics), Distribution Channel, End-Users - Forecast 2024-2030

  • PDF Icon

    Report

  • 187 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5896360
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Dysmenorrhea Treatment Market size was estimated at USD 7.16 billion in 2023, USD 7.80 billion in 2024, and is expected to grow at a CAGR of 8.98% to reach USD 13.09 billion by 2030.

Dysmenorrhea treatment refers to the therapeutic approaches for managing and alleviating the pain and discomfort associated with dysmenorrhea or menstrual cramps. Dysmenorrhea is a prevalent condition affecting a significant proportion of menstruating individuals, characterized by painful abdominal cramping that occurs during or before their menstrual periods.

The treatments for treating dysmenorrhea aim to reduce the pain, improve quality of life, and minimize disruption to daily activities. Meanwhile, the rising awareness about women's reproductive health and government initiatives & programs supporting healthcare facilities for women contribute significantly to the expansion of dysmenorrhea-related treatments.

The increasing number of clinical trials and huge investments by healthcare entities have also contributed to the large-scale dysmenorrhea treatments & diagnosis. However, the lack of reimbursement policies and strict regulations associated with the drugs for menstrual pains is a significant challenge for dysmenorrhea treatment providers. Companies are continuously working toward cutting treatment costs and investing in research activities for novel medications to remain competitive in this evolving market landscape. Moreover, the recent advancements in the therapy of dysmenorrhea and increasing adoption of wearable technology along with digital health services are frequently contributing to the future expansion of dysmenorrhea treatment. Additionally, harnessing data-driven insights using artificial intelligence and machine learning can also aid in developing personalized treatment plans and identifying patterns leading to new therapeutic interventions in dysmenorrhea treatments.

Regional Insights

In American countries, including the United States and Canada, a large percentage of the female population experiences menstrual cramps, including dysmenorrhea. These countries witness various efforts to research and develop effective treatments for this condition with greater awareness of women's health issues. European Union countries have advanced healthcare systems that prioritize women's health, leading to significant funding for research on dysmenorrhea treatment options. For instance, the European Medicines Agency (EMA) has approved various medications targeting menstrual pain relief across European countries.

Furthermore, China, Japan, and India are key markets within the Asia-Pacific region for dysmenorrhea treatment due to their large populations of women experiencing menstrual pain. Traditional medicine plays a crucial role in addressing dysmenorrhea in these countries. Moreover, research initiatives in this region explore the efficacy of alternative therapies, such as acupuncture and moxibustion, in treating dysmenorrhea. In Japan, a mix of traditional and modern medical approaches is adopted to address women's health issues, with patented medications such as Loxoprofen being prescribed for menstrual pain relief. India has observed an increase in investment in menstrual hygiene management and access to affordable healthcare with its growing awareness about women's health issues. The need for effective dysmenorrhea treatments worldwide varies across regions based on cultural factors, healthcare infrastructure, and awareness about women's health issues. Innovations in research and development provide promising opportunities for advancements in dysmenorrhea treatment options.

Market Trends by Segment

  • Type: Wide occurrence of primary dysmenorrhea and extensive need for pain relief management
  • Treatment: Adoption of hysterectomy treatment to provide permanent relief from dysmenorrhea
  • Distribution Channel: Growing preference for online pharmacies due to their convenience, discreteness, and competitive pricing of medications and pain relief patches
  • End-Users: Increasing adoption of dysmenorrhea treatment in the homecare segment as it is easily accessible and cost-effective

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Mithra Submits Marketing Approval Application in Japan to Combat Dysmenorrhea

Mithra Pharmaceuticals, a Belgian biotech company, and Fuji Pharma have collaborated to submit a marketing approval application for ESTELLE in Japan. This collaboration with Fuji Pharma demonstrates Mithra's commitment to reshaping women's health and offering potential breakthroughs on a global scale.

Chime Biologics and Hope Medicine Enter Manufacturing Agreement to Speed up the Launch of First-in-class Antibody Drug HMI-115 Targeting Endometriosis and Androgenic Alopecia

Chime Biologics and Hope Medicine Inc. announced their collaboration to develop and manufacture a first-in-class monoclonal antibody drug, HMI-115. Chime Biologics aimed to collaborate with strategic business partners to provide clinical value and benefit to patients to expedite the process of targeting patients with endometriosis and alopecia.

Mithra to Receive EUR 2.5 Million from Fuji Pharma for Dysmenorrhea Treatment in Japan

Mithra Biotech received a EUR 2.5 million payment for the submission of an application by its license holder, Fuji Pharma, for Japanese marketing approval of ESTELLE. This strategy aims to address dysmenorrhea, a medical condition characterized by abdominal pain, headaches, fatigue, nausea, loss of appetite, and depression during menstruation. The progress made by Mithra Biotech and Fuji Pharma in addressing dysmenorrhea demonstrates their commitment to improving women's health and well-being.

Key Company Profiles

The report delves into recent significant developments in the Dysmenorrhea Treatment Market, highlighting leading vendors and their innovative profiles. These include AA Pharma Inc., Abbott Laboratories, AbbVie Inc., Alfa Pharma GmbH, Alvogen, Inc., ASKA Pharmaceutical Co., Ltd., Bayer AG, Comforté Cream by PMS4PMS, LLC, Cora Life by LYV Life, Inc., Cumberland Pharmaceuticals Inc., Dr. Reddy's Laboratories Ltd., Endo Pharmaceuticals Inc., F. Hoffmann-La Roche AG, Ferring B.V., Gedeon Richter Plc., GlaxoSmithKline PLC, Haleon PLC, Hikma Pharmaceuticals PLC, Johnson & Johnson Services, Inc., LGM Pharma, Livia by iPulse Medical Ltd., Lupin Pharmaceuticals, Inc., Merck & Co., Inc., Micro Labs Limited, Myoovi, Myovant Sciences by Sumitovant Biopharma, Inc., Novartis AG, Ovira, Perrigo Company PLC, Pfizer Inc., Rael, Inc., Sanofi S.A., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited., Teva Pharmaceutical Industries Ltd., and Viatris Inc.

This research report offers invaluable insights into various crucial aspects of the Dysmenorrhea Treatment Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of dysmenorrhea and the need for effective treatment options
5.1.1.2. Growing awareness about women’s reproductive health and government initiatives to expand healthcare for women
5.1.2. Restraints
5.1.2.1. Issues associated with product recalls for dysmenorrhea drugs and devices
5.1.3. Opportunities
5.1.3.1. Advancements in therapy for dysmenorrhea and the emergence of novel drugs
5.1.3.2. Adoption of wearable technology and the proliferation of digital health
5.1.4. Challenges
5.1.4.1. Societal barriers and stigmatization regarding dysmenorrhea management
5.2. Market Segmentation Analysis
5.2.1. Type: Wide occurrence of primary dysmenorrhea and extensive need for pain relief management
5.2.2. Treatment: Adoption of hysterectomy treatment to provide permanent relief from dysmenorrhea
5.2.3. Distribution Channel: Growing preference for online pharmacies due to their convenience, discreteness, and competitive pricing of medications and pain relief patches
5.2.4. End-Users: Increasing adoption of dysmenorrhea treatment in the homecare segment as it is easily accessible and cost-effective
5.3. Market Trend Analysis
5.3.1. Strong dysmenorrhea treatment landscape in the Americas characterized by advanced pharmaceutical options and growing innovation by startups, aiming to provide personalized, digital and patient-centered solutions
5.3.2. Rising women's health awareness necessitates extensive clinical trials and dysmenorrhea treatment commercialization across APAC
5.3.3. Regulatory compliance emphasizes the funding, R&D, clinical trials, and approvals for dysmenorrhea treatment in the EMEA region
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework Analysis
6. Dysmenorrhea Treatment Market, by Type
6.1. Introduction
6.2. Primary Dysmenorrhea
6.3. Secondary Dysmenorrhea
7. Dysmenorrhea Treatment Market, by Treatment
7.1. Introduction
7.2. Medication
7.3. Surgery
7.4. Therapeutics
8. Dysmenorrhea Treatment Market, by Distribution Channel
8.1. Introduction
8.2. Hospital Pharmacy
8.3. Online Pharmacy
8.4. Retail Pharmacy
9. Dysmenorrhea Treatment Market, by End-Users
9.1. Introduction
9.2. Homecare
9.3. Hospitals
9.4. Specialty Clinics
10. Americas Dysmenorrhea Treatment Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Dysmenorrhea Treatment Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Dysmenorrhea Treatment Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Mithra Submits Marketing Approval Application in Japan to Combat Dysmenorrhea
13.3.2. Chime Biologics and Hope Medicine Enter Manufacturing Agreement to Speed up the Launch of First-in-class Antibody Drug HMI-115 Targeting Endometriosis and Androgenic Alopecia
13.3.3. Mithra to Receive EUR 2.5 Million from Fuji Pharma for Dysmenorrhea Treatment in Japan
13.3.4. Sumitomo Pharma and Pfizer in Canada Receive Health Canada Approval for MYFEMBREE
13.3.5. Gedeon Richter and Sumitomo Pharma Receive Positive CHMP Opinion for RYEQO for Treatment of Endometriosis
13.3.6. How New Tech from Montreal Could Help the Fight Against Period Cramps
13.3.7. Chugai and Biofourmis Enter into New Partnership Focused on Data-Driven Virtual Care for Endometriosis-Related Pain
13.3.8. Daré Bioscience Begins Phase I Trial of Primary Dysmenorrhea Therapy
13.3.9. Healthtech Startup Ovira is Helping Women Tackle a Key Problem - Drug-Free Period Pain Relief
13.3.10. Cora Reimagines Period Care with a New Beauty-Inspired Look and Expanded Wellness Portfolio to Make Comfort Accessible for Everyone
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
List of Figures
FIGURE 1. DYSMENORRHEA TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. DYSMENORRHEA TREATMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. DYSMENORRHEA TREATMENT MARKET DYNAMICS
FIGURE 7. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
FIGURE 10. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 12. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
FIGURE 14. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. DYSMENORRHEA TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. DYSMENORRHEA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. DYSMENORRHEA TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY PRIMARY DYSMENORRHEA, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY PRIMARY DYSMENORRHEA, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY SECONDARY DYSMENORRHEA, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY SECONDARY DYSMENORRHEA, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY COMBINED ORAL CONTRACEPTIVE PILLS, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY COMBINED ORAL CONTRACEPTIVE PILLS, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY COX-2 INHIBITORS, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY COX-2 INHIBITORS, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY OVER-THE-COUNTER MEDICATIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY OVER-THE-COUNTER MEDICATIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY TRANSDERMAL GLYCERYL TRINITRATE, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY TRANSDERMAL GLYCERYL TRINITRATE, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY HYSTERECTOMY, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY HYSTERECTOMY, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY INTRAUTERINE DEVICE, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY INTRAUTERINE DEVICE, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY LAPAROSCOPIC UTEROSACRAL NERVE ABLATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY LAPAROSCOPIC UTEROSACRAL NERVE ABLATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY LEVONORGESTREL INTRAUTERINE SYSTEM (LN-IUS), BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY LEVONORGESTREL INTRAUTERINE SYSTEM (LN-IUS), BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY PRESACRAL NEURECTOMY, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY PRESACRAL NEURECTOMY, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY ALTERNATIVE THERAPIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY ALTERNATIVE THERAPIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY PSYCHOLOGICAL THERAPIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY PSYCHOLOGICAL THERAPIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 53. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2023 (USD MILLION)
TABLE 54. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2024-2030 (USD MILLION)
TABLE 55. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2023 (USD MILLION)
TABLE 56. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2024-2030 (USD MILLION)
TABLE 57. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2023 (USD MILLION)
TABLE 58. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2024-2030 (USD MILLION)
TABLE 59. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 60. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 61. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY HOMECARE, BY REGION, 2018-2023 (USD MILLION)
TABLE 62. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY HOMECARE, BY REGION, 2024-2030 (USD MILLION)
TABLE 63. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 64. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 65. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 66. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 67. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 68. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 69. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 70. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 71. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
TABLE 72. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
TABLE 73. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2023 (USD MILLION)
TABLE 74. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2024-2030 (USD MILLION)
TABLE 75. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
TABLE 76. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
TABLE 77. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 78. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 79. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 80. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 81. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 82. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 83. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 84. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 85. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 86. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 87. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
TABLE 88. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
TABLE 89. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2023 (USD MILLION)
TABLE 90. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2024-2030 (USD MILLION)
TABLE 91. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
TABLE 92. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
TABLE 93. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 94. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 95. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 96. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 97. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 98. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 99. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 100. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 101. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
TABLE 102. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
TABLE 103. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2023 (USD MILLION)
TABLE 104. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2024-2030 (USD MILLION)
TABLE 105. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
TABLE 106. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
TABLE 107. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 108. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 109. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 110. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 111. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 112. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 113. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 114. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 115. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
TABLE 116. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
TABLE 117. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2023 (USD MILLION)
TABLE 118. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2024-2030 (USD MILLION)
TABLE 119. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
TABLE 120. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
TABLE 121. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 122. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 123. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 124. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 125. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 126. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 127. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 128. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 129. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
TABLE 130. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
TABLE 131. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2023 (USD MILLION)
TABLE 132. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2024-2030 (USD MILLION)
TABLE 133. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
TABLE 134. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
TABLE 135. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 136. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 137. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 138. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 139. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 140. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 141. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 142. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 143. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
TABLE 144. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
TABLE 145. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2023 (USD MILLION)
TABLE 146. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2024-2030 (USD MILLION)
TABLE 147. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
TABLE 148. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
TABLE 149. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 150. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 151. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 152. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 153. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 154. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 155. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 156. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 157. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 158. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 159. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
TABLE 160. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
TABLE 161. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2023 (USD MILLION)
TABLE 162. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2024-2030 (USD MILLION)
TABLE 163. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
TABLE 164. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
TABLE 165. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 166. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 167. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 168. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 169. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 170. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 171. AUSTRALIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 172. AUSTRALIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 173. AUSTRALIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 174. AUSTRALIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 175. AUSTRALIA DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
TABLE 176. AUSTRALIA DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
TABLE 177. AUSTRALIA DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2023 (USD MILLION)
TABLE 178. AUSTRALIA DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2024-2030 (USD MILLION)
TABLE 179. AUSTRALIA DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
TABLE 180. AUSTRALIA DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
TABLE 181. AUSTRALIA DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 182. AUSTRALIA DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 183. AUSTRALIA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 184. AUSTRALIA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 185. CHINA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 186. CHINA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 187. CHINA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 188. CHINA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 189. CHINA DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
TABLE 190. CHINA DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
TABLE 191. CHINA DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2023 (USD MILLION)
TABLE 192. CHINA DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2024-2030 (USD MILLION)
TABLE 193. CHINA DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
TABLE 194. CHINA DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
TABLE 195. CHINA DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 196. CHINA DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 197. CHINA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 198. CHINA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 199. INDIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 200. INDIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 201. INDIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 202. INDIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 203. INDIA DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
TABLE 204. INDIA DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
TABLE 205. INDIA DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2023 (USD MILLION)
TABLE 206. INDIA DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2024-2030 (USD MILLION)
TABLE 207. INDIA DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
TABLE 208. INDIA DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
TABLE 209. INDIA DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 210. INDIA DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 211. INDIA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 212. INDIA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 213. INDONESIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 214. INDONESIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 215. INDONESIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 216. INDONESIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 217. INDONESIA DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
TABLE 218. INDONESIA DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
TABLE 219. INDONESIA DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2023 (USD MILLION)
TABLE 220. INDONESIA DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2024-2030 (USD MILLION)
TABLE 221. INDONESIA DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
TABLE 222. INDONESIA DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
TABLE 223. INDONESIA DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 224. INDONESIA DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 225. INDONESIA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 226. INDONESIA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 227. JAPAN DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 228. JAPAN DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 229. JAPAN DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 230. JAPAN DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 231. JAPAN DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
TABLE 232. JAPAN DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
TABLE 233. JAPAN DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2023 (USD MILLION)
TABLE 234. JAPAN DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2024-2030 (USD MILLION)
TABLE 235. JAPAN DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
TABLE 236. JAPAN DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
TABLE 237. JAPAN DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 238. JAPAN DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 239. JAPAN DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 240. JAPAN DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 241. MALAYSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 242. MALAYSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 243. MALAYSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 244. MALAYSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 245. MALAYSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
TABLE 246. MALAYSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
TABLE 247. MALAYSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2023 (USD MILLION)
TABLE 248. MALAYSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2024-2030 (USD MILLION)
TABLE 249. MALAYSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
TABLE 250. MALAYSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
TABLE 251. MALAYSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 252. MALAYSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 253. MALAYSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 254. MALAYSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 255. PHILIPPINES DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 256. PHILIPPINES DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 257. PHILIPPINES DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 258. PHILIPPINES DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 259. PHILIPPINES DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
TABLE 260. PHILIPPINES DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
TABLE 261. PHILIPPINES DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2023 (USD MILLION)
TABLE 262. PHILIPPINES DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2024-2030 (USD MILLION)
TABLE 263. PHILIPPINES DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
TABLE 264. PHILIPPINES DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
TABLE 265. PHILIPPINES DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 266. PHILIPPINES DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 267. PHILIPPINES DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 268. PHILIPPINES DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 269. SINGAPORE DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 270. SINGAPORE DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 271. SINGAPORE DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 272. SINGAPORE DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 273. SINGAPORE DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
TABLE 274. SINGAPORE DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
TABLE 275. SINGAPORE DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2023 (USD MILLION)
TABLE 276. SINGAPORE DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2024-2030 (USD MILLION)
TABLE 277. SINGAPORE DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
TABLE 278. SINGAPORE DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
TABLE 279. SINGAPORE DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 280. SINGAPORE DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 281. SINGAPORE DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 282. SINGAPORE DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 283. SOUTH KOREA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 284. SOUTH KOREA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 285. SOUTH KOREA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 286. SOUTH KOREA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 287. SOUTH KOREA DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
TABLE 288. SOUTH KOREA DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
TABLE 289. SOUTH KOREA DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2023 (USD MILLION)
TABLE 290. SOUTH KOREA DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2024-2030 (USD MILLION)
TABLE 291. SOUTH KOREA DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
TABLE 292. SOUTH KOREA DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
TABLE 293. SOUTH KOREA DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 294. SOUTH KOREA DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 295. SOUTH KOREA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 296. SOUTH KOREA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 297. TAIWAN DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 298. TAIWAN DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 299. TAIWAN DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 300. TAIWAN DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 301. TAIWAN DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
TABLE 302. TAIWAN DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
TABLE 303. TAIWAN DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2023 (USD MILLION)
TABLE 304. TAIWAN DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2024-2030 (USD MILLION)
TABLE 305. TAIWAN DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
TABLE 306. TAIWAN DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
TABLE 307. TAIWAN DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 308. TAIWAN DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 309. TAIWAN DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 310. TAIWAN DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 311. THAILAND DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 312. THAILAND DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 313. THAILAND DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 314. THAILAND DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 315. THAILAND DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
TABLE 316. THAILAND DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
TABLE 317. THAILAND DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2023 (USD MILLION)
TABLE 318. THAILAND DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2024-2030 (USD MILLION)
TABLE 319. THAILAND DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
TABLE 320. THAILAND DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
TABLE 321. THAILAND DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 322. THAILAND DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 323. THAILAND DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 324. THAILAND DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 325. VIETNAM DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 326. VIETNAM DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 327. VIETNAM DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 328. VIETNAM DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 329. VIETNAM DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
TABLE 330. VIETNAM DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
TABLE 331. VIETNAM DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2023 (USD MILLION)
TABLE 332. VIETNAM DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2024-2030 (USD MILLION)
TABLE 333. VIETNAM DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
TABLE 334. VIETNAM DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
TABLE 335. VIETNAM DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 336. VIETNAM DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 337. VIETNAM DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 338. VIETNAM DYSMENORRHEA TREATMENT MARK

Companies Mentioned

  • AA Pharma Inc.
  • Abbott Laboratories
  • AbbVie Inc.
  • Alfa Pharma GmbH
  • Alvogen, Inc.
  • ASKA Pharmaceutical Co., Ltd.
  • Bayer AG
  • Comforté Cream by PMS4PMS, LLC
  • Cora Life by LYV Life, Inc.
  • Cumberland Pharmaceuticals Inc.
  • Dr. Reddy's Laboratories Ltd.
  • Endo Pharmaceuticals Inc.
  • F. Hoffmann-La Roche AG
  • Ferring B.V.
  • Gedeon Richter Plc.
  • GlaxoSmithKline PLC
  • Haleon PLC
  • Hikma Pharmaceuticals PLC
  • Johnson & Johnson Services, Inc.
  • LGM Pharma
  • Livia by iPulse Medical Ltd.
  • Lupin Pharmaceuticals, Inc.
  • Merck & Co., Inc.
  • Micro Labs Limited
  • Myoovi
  • Myovant Sciences by Sumitovant Biopharma, Inc.
  • Novartis AG
  • Ovira
  • Perrigo Company PLC
  • Pfizer Inc.
  • Rael, Inc.
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Company Limited.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages187
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 7.8 Billion
Forecasted Market Value ( USD ) by 2030 $ 13.09 Billion
Compound Annual Growth Rate8.9%
Regions CoveredGlobal
No. of Companies Mentioned36

Related Topics

Related Reports

Dysmenorrhea Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Image

Dysmenorrhea Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • 178 Pages
  • Global
From
Dysmenorrhea Market Report and Forecast 2024-2032 - Product Image

Dysmenorrhea Market Report and Forecast 2024-2032

  • Report
  • 180 Pages
  • Global
From
Dysmenorrhea - Pipeline Insight, 2024 - Product Image

Dysmenorrhea - Pipeline Insight, 2024

  • Clinical Trials
  • 60 Pages
  • Global
From
Menstrual Cramps Treatment Market by Type, Treatment, Distribution Channel, and Geography: Forecast up to 2027 - Product Image

Menstrual Cramps Treatment Market by Type, Treatment, Distribution Channel, and Geography: Forecast up to 2027

  • Report
  • 184 Pages
  • Global
From
Gynecological Examination Chairs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Gynecological Examination Chairs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 111 Pages
  • Global
From

About the Dysmenorrhea Drug Market

Dysmenorrhea Drug is a type of medication used to treat the pain associated with menstrual cramps. It is a common condition that affects many women of reproductive age. Dysmenorrhea Drug is a part of the Sexual and Reproductive Health Drugs market, which includes medications used to treat a variety of conditions related to sexual and reproductive health. These drugs are used to treat conditions such as infertility, endometriosis, and menopause. They can also be used to prevent pregnancy and to treat sexually transmitted infections. The Dysmenorrhea Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Bayer AG, Pfizer Inc., Merck & Co., Inc., and GlaxoSmithKline plc. Other companies in the market include Allergan plc, Teva Pharmaceutical Industries Ltd., and Mylan N.V. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.